Clinuvel Pharmaceuticals (CLVLY)

[ghmm]

Don't know what they'll discuss/answer questions to but I am very disgusted with what I read in both the chairman's comments and the slide presentation. Didn't see a mention of a US filing but some slides on CLVLY so maybe they talk about it?

I posted these on sharescene

I read the letter and two things stick out.
1-Why is someone not fluent in German (not to mention their reimbursement process and IQWIG) doing the discussion.
2-Why is a tiny biotech trying to "revolutionize" the uniform pricing (when it clearly doesn't work!)

on top the annual

So the FDA filing is delayed yet again! So much for 2018. Looks like if all things go well we'll be lucky for 2019! And First patient treated not till ~10 months later! What the heck are they (not) doing!

What are they doing talking about acquisitions too? Lets get one thing across the finish line and best if we get bought out IMO!

Management is really inept! They need to be held accountable to shareholders and execute better they need to go and get people who know what they are doing!!